© 2004 by Oxford University Press
© 2004 Oxford University Press
CORRESPONDENCE |
Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
Affiliations of authors: Division of Breast Surgery (MI,UV), Division of Epidemiology and Biostatistics (NR), European Institute of Oncology, Milan, Italy; University of Milan School of Medicine, Milan (GV)
Correspondence to: Mattia Intra, MD, Breast Surgery Division, European Institute of Oncology, Via Ripamonti, 435, 20141 Milan, Italy (e-mail: mattia.intra@ieo.it)
| The first 10% of the full text of this article appears below. |
The treatment of ductal carcinoma in situ (DCIS) of the breast still represents a hotly debated issue, and wide variations in surgical management of DCIS have been recently reported (1). In particular, although the appropriateness of sentinel lymph node biopsy (SLNB) in the management of pure DCIS seems well established today because of the very low rate of axillary metastases and
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Intra, G. Trifiro, G. Viale, N. Rotmensz, O. D. Gentilini, J. Soteldo, V. Galimberti, P. Veronesi, A. Luini, G. Paganelli, et al. Second Biopsy of Axillary Sentinel Lymph Node for Reappearing Breast Cancer After Previous Sentinel Lymph Node Biopsy Ann. Surg. Oncol., November 1, 2005; 12(11): 895 - 899. [Abstract] [Full Text] [PDF] |
||||
